0001819113-23-000035.txt : 20230502 0001819113-23-000035.hdr.sgml : 20230502 20230502162339 ACCESSION NUMBER: 0001819113-23-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230428 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coman David CENTRAL INDEX KEY: 0001886837 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39727 FILM NUMBER: 23879421 MAIL ADDRESS: STREET 1: C/O LIFESCI ACQUISITION II CORP. STREET 2: 250 W 55TH STREET, #3401 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Science 37 Holdings, Inc. CENTRAL INDEX KEY: 0001819113 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 844278203 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 PARK OFFICES DRIVE STREET 2: SUITE 3606 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (984) 377-3737 MAIL ADDRESS: STREET 1: 800 PARK OFFICES DRIVE STREET 2: SUITE 3606 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: Lifesci Acquisition II Corp. DATE OF NAME CHANGE: 20200723 4 1 wf-form4_168305900277202.xml FORM 4 X0407 4 2023-04-28 0 0001819113 Science 37 Holdings, Inc. SNCE 0001886837 Coman David 800 PARK OFFICES DRIVE, SUITE 3606 RESEARCH TRIANGLE PARK NC 27709 0 1 0 0 Chief Executive Officer 0 Common Stock 2023-04-28 4 A 0 615650 A 1341787 D Stock Option 10.05 2023-04-28 4 D 0 981437 D 2031-10-07 Common Stock 981437.0 0 D Stock Option 11.47 2023-04-28 4 D 0 557692 D 2032-01-07 Common Stock 557692.0 0 D On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 981,437 shares of common stock of the issuer and in exchange issued to the reporting person 392,574 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock. On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 557,692 shares of common stock of the issuer and in exchange issued to the reporting person 223,076 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock. Includes 615,650 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment. /s/ Christine Pellizzari, Attorney-in-fact for David Coman 2023-05-02